| RHYTHM PHARMACEUTICALS |
| USA |
| Gesundheit |
| US76243J1051 / A2H5A0 |
| 1RV (Frankfurt) / RYTM (NASDAQ) |
| FRA:1RV, ETR:1RV, 1RV:GR, NASDAQ:RYTM |
| - |
| https://www.rhythmtx.com/ |
|
Rhythm Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapies for rare genetic disorders of obesity. The company’s flagship product, Setmel..
>Volltext.. |
| 5359.74 Mio. EUR |
| 5235.78 Mio. EUR |
| 160.62 Mio. EUR |
| -161.4 Mio. EUR |
| -166.36 Mio. EUR |
| -2.63 EUR |
| 205.8 Mio. EUR |
| 45.96 Mio. EUR |
| -97.91 Mio. EUR |
| 3.67 |
| 28.53% |
| 33.52% |
| - |
| - |
| - |
| RHYTHM PHARMACEUTICALS, RHYTHM PHARMA, RHYTHM PHARMACEUTICAL |
| 01.03.26 |
|